These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8907547)

  • 1. Different electrophoretic techniques produce conflicting data in the analysis of myocardial samples from dilated cardiomyopathy patients: protein levels do not necessarily reflect mRNA levels.
    dos Remedios CG; Berry DA; Carter LK; Coumans JV; Heinke MY; Kiessling PC; Seeto RK; Thorvaldson T; Trahair T; Yeoh T; Yao M; Gunning PW; Hardeman E; Humphery-Smith I; Naidoo D; Keogh A
    Electrophoresis; 1996 Jan; 17(1):235-8. PubMed ID: 8907547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in the relative mRNA levels of actins and myosin heavy chains do not produce corresponding differences in their proteins in the adult human heart.
    Coumans JV; Yeoh T; Seeto RK; Keogh A; Brennan K; Gunning P; Hardeman E; dos Remedios CG
    J Mol Cell Cardiol; 1997 Mar; 29(3):895-905. PubMed ID: 9152850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of P2X1alpha-sarcoglycan (adhalin) expression levels in failing human dilated cardiomyopathic left ventricles.
    Berry DA; Balcar VJ; Barden JA; Keogh A; dos Remedios CG
    Electrophoresis; 2000 Nov; 21(17):3857-62. PubMed ID: 11271504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis.
    Corbett JM; Why HJ; Wheeler CH; Richardson PJ; Archard LC; Yacoub MH; Dunn MJ
    Electrophoresis; 1998 Aug; 19(11):2031-42. PubMed ID: 9740065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy.
    Szotowski B; Goldin-Lang P; Antoniak S; Bogdanov VY; Pathirana D; Pauschinger M; Dörner A; Kuehl U; Coupland S; Nemerson Y; Hummel M; Poller W; Hetzer R; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2005 Apr; 45(7):1081-9. PubMed ID: 15808768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients.
    Warraich RS; Dunn MJ; Yacoub MH
    Biochem Biophys Res Commun; 1999 Jun; 259(2):255-61. PubMed ID: 10362496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular chaperone, HSP60, and cytochrome P450 2E1 co-expression in dilated cardiomyopathy.
    Sidorik L; Kyyamova R; Bobyk V; Kapustian L; Rozhko O; Vigontina O; Ryabenko D; Danko I; Maksymchuk O; Kovalenko VN; Filonenko VV; Chaschin NA
    Cell Biol Int; 2005 Jan; 29(1):51-5. PubMed ID: 15763499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
    Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
    J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilated cardiomyopathy-associated proteins and their presentation in a WWW-accessible two-dimensional gel protein database.
    Pleissner KP; Söding P; Sander S; Oswald H; Neuss M; Regitz-Zagrosek V; Fleck E
    Electrophoresis; 1997 May; 18(5):802-8. PubMed ID: 9194611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling of dystrophin and sarcomeric Z-band occurs in pediatric cardiomyopathies: a unifying mechanism for force transmission defect.
    Vatta M; Sinagra G; Brunelli L; Faulkner G
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):149-56. PubMed ID: 19194174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in composition of cardiac myosin light chains in dilated cardiomyopathy: effect on functional properties].
    Khalina IaN; Udal'tsov SN; Podlubnaia ZA
    Biofizika; 2002; 47(2):361-6. PubMed ID: 11969177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed cell death in idiopathic dilated cardiomyopathy is mediated by suppression of the apoptosis inhibitor Apollon.
    Aharinejad S; Andrukhova O; Lucas T; Zuckermann A; Wieselthaler G; Wolner E; Grimm M
    Ann Thorac Surg; 2008 Jul; 86(1):109-14; discussion 114. PubMed ID: 18573408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy.
    Bies RD; Maeda M; Roberds SL; Holder E; Bohlmeyer T; Young JB; Campbell KP
    J Mol Cell Cardiol; 1997 Dec; 29(12):3175-88. PubMed ID: 9441825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.
    Skurk C; Wittchen F; Suckau L; Witt H; Noutsias M; Fechner H; Schultheiss HP; Poller W
    Eur Heart J; 2008 May; 29(9):1168-80. PubMed ID: 18390538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
    Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB
    Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.
    Vatta M; Stetson SJ; Jimenez S; Entman ML; Noon GP; Bowles NE; Towbin JA; Torre-Amione G
    J Am Coll Cardiol; 2004 Mar; 43(5):811-7. PubMed ID: 14998622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular wall stress as a direct correlate of cardiomyocyte apoptosis in patients with severe dilated cardiomyopathy.
    Di Napoli P; Taccardi AA; Grilli A; Felaco M; Balbone A; Angelucci D; Gallina S; Calafiore AM; De Caterina R; Barsotti A
    Am Heart J; 2003 Dec; 146(6):1105-11. PubMed ID: 14661007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression and autoimmunity of recombination signal binding protein-jkappa in human dilated cardiomyopathy.
    Nickenig G; Wolff M; Stäblein A; Pfister H; Böhm M
    Biochem Biophys Res Commun; 1999 Dec; 266(2):432-6. PubMed ID: 10600520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between toll-like receptor 8 expression and adverse clinical outcomes in patients with enterovirus-associated dilated cardiomyopathy.
    Satoh M; Akatsu T; Ishikawa Y; Minami Y; Takahashi Y; Nakamura M
    Am Heart J; 2007 Sep; 154(3):581-8. PubMed ID: 17719310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.